---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-048745"
form_type: "8-K"
ticker: "SLNO"
cik: "0001484565"
company_name: "SOLENO THERAPEUTICS INC"
filed_at: "2023-02-24T23:59:59+00:00"
generated_at: "2026-06-19T00:39:48.346235+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Soleno Therapeutics adds 500,000 shares to inducement equity plan for new hires

## Summary
- Board amended 2020 Inducement Plan to increase share reserve by 500,000 shares.
- Amendment adopted without stockholder approval under Nasdaq Rule 5635(c)(4).
- Plan used for equity awards as material inducement for new employees not previously employed.
- Total shares authorized under plan now 2,000,000 (original 1,500,000 + 500,000).
- Awards may include options, RSUs, restricted stock, SARs, performance shares/units.

## SEC filing metadata
- accession: 0001193125-23-048745
- form_type: 8-K
- ticker: SLNO
- cik: 0001484565
- company_name: SOLENO THERAPEUTICS INC
- filed_at: 2023-02-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484565/000119312523048745/0001193125-23-048745-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484565/000119312523048745/d420661d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-048745
- JSON: https://secwatch.observer/filing/0001193125-23-048745.json
- Plain text: https://secwatch.observer/filing/0001193125-23-048745.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.